These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33569386)

  • 1. Serum Total Bilirubin and Progression of Chronic Kidney Disease and Mortality: A Systematic Review and Meta-Analysis.
    Li J; Liu D; Liu Z
    Front Med (Lausanne); 2020; 7():549. PubMed ID: 33569386
    [No Abstract]   [Full Text] [Related]  

  • 2. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum uric acid and mortality in chronic kidney disease: A systematic review and meta-analysis.
    Xia X; Luo Q; Li B; Lin Z; Yu X; Huang F
    Metabolism; 2016 Sep; 65(9):1326-41. PubMed ID: 27506740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated bilirubin levels and risk of developing chronic kidney disease: a dose-response meta-analysis and systematic review of cohort studies.
    Wang J; Guo P; Gao Z; Zhou B; Ren L; Chen Y; Zhou Q
    Int Urol Nephrol; 2018 Feb; 50(2):275-287. PubMed ID: 28808864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.
    Xiong J; He T; Wang M; Nie L; Zhang Y; Wang Y; Huang Y; Feng B; Zhang J; Zhao J
    J Nephrol; 2019 Oct; 32(5):791-802. PubMed ID: 30888644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Fetuin-A and Risk of All-Cause Mortality in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Zhou Z; Ji Y; Ju H; Chen H; Sun M
    Front Physiol; 2019; 10():966. PubMed ID: 31417425
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies.
    Da J; Xie X; Wolf M; Disthabanchong S; Wang J; Zha Y; Lv J; Zhang L; Wang H
    Am J Kidney Dis; 2015 Aug; 66(2):258-65. PubMed ID: 25804679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frailty and mortality among patients with chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis.
    Zhang Q; Ma Y; Lin F; Zhao J; Xiong J
    Int Urol Nephrol; 2020 Feb; 52(2):363-370. PubMed ID: 31975149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Total Bilirubin and Risk of Cancer: A Swedish Cohort Study and Meta-Analysis.
    Monroy-Iglesias MJ; Moss C; Beckmann K; Hammar N; Walldius G; Bosco C; Van Hemelrijck M; Santaolalla A
    Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease.
    Smart NA; Dieberg G; Ladhani M; Titus T
    Cochrane Database Syst Rev; 2014 Jun; (6):CD007333. PubMed ID: 24938824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum uric acid and cardiovascular mortality in chronic kidney disease: a meta-analysis.
    Luo Q; Xia X; Li B; Lin Z; Yu X; Huang F
    BMC Nephrol; 2019 Jan; 20(1):18. PubMed ID: 30642279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Hypertension, Mortality, and Cardiovascular Disease in CKD and ESRD Patients: A Systematic Review and Meta-analysis.
    Tang M; Batty JA; Lin C; Fan X; Chan KE; Kalim S
    Am J Kidney Dis; 2018 Jul; 72(1):75-83. PubMed ID: 29429751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminatory capacity of serum total bilirubin between complicated and uncomplicated acute appendicitis in children: a systematic review and a diagnostic test accuracy meta-analysis.
    Arredondo Montero J; Rico Jiménez M; Martín-Calvo N
    Pediatr Surg Int; 2022 Dec; 39(1):64. PubMed ID: 36574051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
    Dahal K; Kunwar S; Rijal J; Schulman P; Lee J
    Chest; 2016 Apr; 149(4):951-9. PubMed ID: 26378611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid A and risks of all-cause and cardiovascular mortality in chronic kidney disease: a systematic review and dose-response meta-analysis.
    Li L; Liu H; Zhang Q; Jin H; Tao H; Zhu R; Zhou Z
    Ren Fail; 2023; 45(2):2250877. PubMed ID: 37930241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum sodium and risk of all-cause mortality in patients with chronic kidney disease: A meta-analysis and sysematic review.
    Sun L; Hou Y; Xiao Q; Du Y
    Sci Rep; 2017 Nov; 7(1):15949. PubMed ID: 29162909
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.